Clinical studies recruiting near Montclair

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Catalina Research Institute, LLC · Bristol-Myers Squibb · NCT06929273 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Catalina Research Institute, LLC · Hoffmann-La Roche · NCT07351058 A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · Catalina Research Institute, LLC · Bristol-Myers Squibb · NCT07140913 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Catalina Research Institute, LLC · Boehringer Ingelheim · NCT06632457 Online Rotating Delivery of Perception/Production Enhanced Treatment for Rhotics
NA · Montclair State University · Montclair State University · NCT06969521 BiOfeedback, Online for Sibilant Treatment
NA · Montclair State University · NCT07041723 Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While U
Phase 2 · Catalina Research Institute, LLC · Biomea Fusion Inc. · NCT07502508 A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Phase 3 · Catalina Research Institute Site · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06894212 A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic
Phase 2 · Catalina Research Institute · Rivus Pharmaceuticals, Inc. · NCT07491458 Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial
Phase 2 · New York University · NCT06517225 "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Phase 3 · Catalina Research Institute · Cybin IRL Limited · NCT06564818 Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
NA · Aptitude Medical Systems · NCT06744660 Shield Post-Approval Study Protocol
Phase N/A · Gastroenterology Associates of New Jersey, LLC · Guardant Health, Inc. · NCT06880055 A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I
Phase 2 · Catalina Research Institute /ID# 272831 · AbbVie · NCT06696755 A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction-
Phase 2 · Catalina Research Institute, LLC · Boehringer Ingelheim · NCT07325526 LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or A
Phase 3 · Catalina Research Institute, LLC · Boehringer Ingelheim · NCT06632444 Generalization With AI Navigation Using StaRt
Phase 2 · New York University · NCT06884943 Brain Activity Changes After Cognitive Behavioral Therapy for Anxiety in Autistic Youth From High-Need Communities
NA · Montclair State University · Montclair State University · NCT06904508 Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Phase 2 · Catalina Research Institute, LLC · Biomea Fusion Inc. · NCT07502495 A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabe
Phase 2 · Catalina Research Institute, LLC · Novo Nordisk A/S · NCT07668388 A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07221227 A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06318169 An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Phase 3 · Catalina Research Institute · Transcend Therapeutics · NCT07456696 A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Phase 2 · Catalina Research Institute, LLC · Eli Lilly and Company · NCT07269210 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Phase 3 · Catalina Research Institute, LLC · Bristol-Myers Squibb · NCT06951698 A Study of Brenipatide in Adult Participants With Schizophrenia
Phase 2 · Catalina Research Institute, LLC · Eli Lilly and Company · NCT07410507 Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabete
Phase 3 · Kailera Clinical Site · Kailera · NCT07284901 A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Phase 2 · Catalina Research Institute, LLC · Syndeio Biosciences, Inc · NCT07115329

Look up another city

Look up another condition